Related references
Note: Only part of the references are listed.Intracytoplasmic sperm injection use in states with and without insurance coverage mandates for infertility treatment, United States, 2000-2015
Ada C. Dieke et al.
FERTILITY AND STERILITY (2018)
Temporal Differences in Utilization of Intracytoplasmic Sperm Injection Among US Regions
Pavel Zagadailov et al.
OBSTETRICS AND GYNECOLOGY (2018)
Differences in utilization of Intracytoplasmic sperm injection (ICSI) within human services (HHS) regions and metropolitan megaregions in the U.S
Pavel Zagadailov et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2017)
State Insurance Mandates and Multiple Birth Rates After In Vitro Fertilization
Meredith P. Provost et al.
OBSTETRICS AND GYNECOLOGY (2016)
Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE
A. P. Ferraretti et al.
HUMAN REPRODUCTION (2013)
Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis
Juan Wen et al.
FERTILITY AND STERILITY (2012)
Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion
FERTILITY AND STERILITY (2012)
Trends in the use of intracytoplasmic sperm injection in the United States
Tarun Jain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Intracytoplasmic sperm injection may increase the risk of imprinting defects
GF Cox et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Share Paper
